查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2014835

術中放射治療市場：依技術、產品類型、手術/手術方法、手術環境、癌症類型和最終用戶分類－2026-2032年全球市場預測

Intraoperative Radiation Therapy Market by Technology, Product Type, Procedure / Surgical Approach, Procedure Setting, Cancer Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，術中放射治療市場價值將達到 2.5177 億美元，到 2026 年將成長至 2.8419 億美元，到 2032 年將達到 5.9367 億美元，複合年成長率為 13.03%。

主要市場統計數據
基準年 2025 2.5177億美元
預計年份：2026年 2.8419億美元
預測年份 2032 5.9367億美元
複合年成長率 (%) 13.03%

術中放射治療融合了外科手術的精準性和標靶放射治療的優勢，提供了一種整合治療流程並減少周邊健康組織輻射暴露的單一治療模式。過去十年，小型放射治療系統的進步和臨床方案的改進拓展了術中放射治療的適應症和治療環境。隨著攜帶式平台和低能量設備的不斷創新，術中放射治療正從高度專業化的三級醫療機構轉向整個癌症治療網路的更廣泛應用。

臨床團隊日益將術中放射治療（IORT）視為簡化手術全期工作流程的一種手段，有研究表明，IORT 或許還能減少某些患者群體長期接受體外放射治療的需求。這一趨勢得益於外科醫生、放射腫瘤科醫生、醫學物理學家和護理人員之間的多學科協作，而這種協作對於將 IORT 整合到現有的外科和腫瘤臨床流程中至關重要。同時，設備製造商也致力於提升設備的人體工學設計、屏蔽效率和易整合性，以降低手術的複雜性，並促進其在臨床實踐中的廣泛應用。

監管機構和專業協會正在完善患者選擇、輻射安全和培訓標準方面的指南，以確保實施的一致性和高品質。同時，醫療保健系統正在評估報銷框架和交付模式，以平衡初始資本投資與潛在的營運效率和以患者為中心的治療效果。這些因素共同為臨床計畫負責人、醫療設備製造商和保險公司製定策略決策奠定了基礎，幫助他們評估術中放射治療在現代腫瘤治療中的作用。

臨床實踐、技術和醫療保健服務的變革性變化將推動術中放射線治療在整個醫療保健系統中得到更廣泛的研究和運作整合。

目前術中放射治療正經歷著一場變革，其驅動力包括技術小型化、流程標準化以及醫療服務環境的改變。設備創新主要集中在提高劑量分佈均勻性、減少屏蔽需求以及確保設備便攜性，這些改進共同降低了術中放射治療在門診和社區醫院環境中的應用門檻。因此，與老一代設備相比，臨床團隊現在可以考慮在腫瘤切除部位進行放射治療，且精確度更高，後勤限制也更少。

本研究評估了近期關稅和貿易趨勢如何影響術中放射治療系統的採購決策、供應鏈韌性和部署策略。

影響醫療設備進口的關稅政策會對供應鏈、籌資策略以及部署先進術中放射治療系統的經濟效益產生連鎖反應。關稅增加和貿易限制會提高進口設備和組件的成本，迫使採購機構重新考慮採購時機、資金籌措安排和供應商選擇。當採購團隊預測進口成本波動時，他們通常會採取與本地製造地合作或多元化採購管道的策略來降低風險。

關鍵細分分析，以闡明臨床應用、放射技術和醫療環境如何結合起來決定導入途徑和手術設計的選擇。

細分分析揭示了適應症、技術和最終用戶三個維度上，該技術在應用因素和臨床價值方面存在細微差異。根據適應症，該技術應用於腦腫瘤、乳癌和婦科腫瘤，每種腫瘤都有其獨特的手術流程、劑量需求和多學科協作需求，這些都會影響設備的選擇和方案設計。腦腫瘤手術通常需要高精度和特殊的防護措施，而乳癌病例則為採用與乳房保留策略相關的單次照射方法提供了機會。此外，在婦科惡性腫瘤中，對於複雜的骨盆腔切除術，術中追加照射可用於控制切緣。

影響全球醫療保健市場臨床計畫發展、報銷制度調整和分銷策略的區域趨勢和採用模式。

不同地區對術中放射放射線治療的觀點凸顯了各主要地區所面臨的不同促進因素和障礙。在美洲，臨床網路和三級醫療機構率先採用者，這得益於其強大的腫瘤外科計畫以及對手術全期護理整合的重視。然而，在那些項目已擴展到主要大都會圈以外的地區，報銷政策和資金週期的差異正在影響這些地區。隨著醫療服務提供者努力改善其所在社區獲得先進腫瘤治療的機會，區域醫院和特定門診機構的轉型工作正變得日益重要。

策略競爭定位和服務主導的差異化因素影響術中放射治療計畫的供應商選擇、臨床實施和長期永續性。

術中放射線治療領域的競爭格局涵蓋了成熟的醫療設備製造商、專業的放射治療公司以及專注於創新放射治療平台和服務的新興企業公司。每家公司都透過技術進步來脫穎而出，例如小型化發生器、最佳化的施用器以及整合的成像和導航支援系統，這些技術能夠提高靶向精度和手術效率。策略重點包括減輕屏蔽負擔、縮短準備時間、減少操作摩擦，並透過與手術流程的無縫整合來提高手術效率。

為醫療保健主管和臨床領導者提供實施術中放射治療方案的實用建議，以實現操作的嚴謹性和可衡量的結果。

考慮實施術中放射治療（IORT）的領導者應優先考慮兼顧臨床價值和操作可行性的可行步驟。首先，應建立一個涵蓋外科、放射腫瘤科、醫學物理科、護理科和管理階層等相關人員的多學科管治結構，並負責制定可重複的治療方案、定義安全檢查清單和培訓流程。各團隊之間的早期協作將有助於加快就患者選擇標準和操作職責達成共識，降低實施風險，並確保醫療品質的一致性。

高度透明的調查方法，結合與專家的初步訪談、臨床和監管方面的二次分析以及三角檢驗，確保了可操作和可靠的見解。

本分析採用定性和定量相結合的研究途徑，旨在全面了解術中放射線治療的普及現狀、供應趨勢和臨床實踐模式。主要調查包括對外科腫瘤學家、放射腫瘤學家、醫學物理學家、採購經理和醫療設備專家的訪談，以深入了解現場操作情況，並識別實際應用中遇到的障礙和促進因素。次要分析則利用同儕審查的臨床文獻、監管文件、醫療系統報告和公開的技術規範來佐證臨床和技術方面的論點。

本文概述了技術進步和運作準備如何決定術中放射線治療在腫瘤治療路徑中的永續整合。

術中放射線治療正處於一個轉折點，技術成熟、臨床證據和服務模式創新在此交匯融合，為手術全期癌症治療開闢了新的途徑。能夠降低操作複雜性和屏蔽要求的醫療設備，結合標準化培訓和多學科管治，為術中放射治療在早期用戶之外的廣泛應用創造了切實可行的路徑。這項發展有望將局部控制策略整合到單階段手術治療中，同時也要求認真考慮實施的物流以及對長期服務交付的承諾。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：術中放射治療市場：依技術分類

  • 電子束
  • 低能量X光
  • 攜帶式X光機

第9章 術中放射治療市場：依產品類型分類

  • 術中放射治療設備/放射系統
    • 移動式電子束加速器
    • 緊湊型X光術中放射治療系統
  • 施用器和配件
    • 球形施用器
    • 扁平式施用器

第10章：以手術方式/手術入路分類的術中放射治療市場

  • 乳房保留手術（BCS）
  • 癌症手術期間對腫瘤床進行額外的放射治療
  • 腫瘤減重手術 + 額外放射治療

第11章：依實施環境分類的術中放射治療市場

  • 醫院手術
  • 門診/日間手術

第12章：以癌症類型分類的術中放射治療市場

  • 腦腫瘤
  • 乳癌
  • 婦科癌症

第13章 術中放射治療市場：依最終使用者分類

  • 門診手術中心
  • 癌症中心
  • 醫院

第14章 術中放射治療市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 術中放射治療市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 術中放射治療市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國術中放射治療市場

第18章：中國術中放射治療市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Accuray Incorporated
  • Aries Medical Systems Ltd.
  • Brainlab AG
  • Carl Zeiss Meditec AG
  • Eckert & Ziegler Radiopharma
  • Elekta AB
  • GMV Innovating Solutions
  • iCAD, Inc.
  • InfoMedics AG
  • IntraOp Medical, Inc.
  • Ion Beam Applications SA
  • Isoray, Inc.
  • Panacea Medical Technologies Pvt. Ltd.
  • Salutaris Medical Devices
  • Sensus Healthcare, Inc.
  • Sordina IORT Technologies
  • Varian Medical Systems, Inc.
Product Code: MRR-43127F7279F0

The Intraoperative Radiation Therapy Market was valued at USD 251.77 million in 2025 and is projected to grow to USD 284.19 million in 2026, with a CAGR of 13.03%, reaching USD 593.67 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 251.77 million
Estimated Year [2026] USD 284.19 million
Forecast Year [2032] USD 593.67 million
CAGR (%) 13.03%

Intraoperative radiation therapy represents a convergence of surgical precision and targeted radiotherapeutic delivery, offering a single-encounter treatment paradigm that reduces radiation exposure to surrounding healthy tissue while consolidating care pathways. Over the past decade, advancements in compact radiation delivery systems and refinements in clinical protocols have expanded the range of indications and settings in which IORT can be considered. With ongoing innovation in portable platforms and low-energy devices, IORT is transitioning from highly specialized tertiary centers toward broader adoption across cancer care networks.

Clinical teams increasingly view IORT as a means to streamline perioperative workflows, potentially reducing the need for prolonged external beam radiotherapy in selected patient cohorts. This trend is supported by multidisciplinary collaboration among surgeons, radiation oncologists, medical physicists, and nursing staff, which is essential to integrate IORT into existing surgical and oncologic pathways. Concurrently, device makers have focused on ergonomics, shielding efficiency, and ease of integration to lower procedural complexity and support wider clinical uptake.

Regulatory authorities and professional societies have been refining guidance around patient selection, radiation safety, and training standards to ensure consistent, high-quality implementation. In parallel, health systems are evaluating reimbursement frameworks and care delivery models to balance upfront capital investment with potential operational efficiencies and patient-centric outcomes. Taken together, these dynamics set the stage for strategic decisions by clinical program leaders, device manufacturers, and payers seeking to evaluate the role of IORT within contemporary oncologic care.

Transformative clinical, technological, and care-delivery shifts driving broader consideration and operational integration of intraoperative radiation therapy across health systems

The landscape of intraoperative radiation therapy is undergoing transformative shifts driven by technological miniaturization, procedural standardization, and shifts in care delivery settings. Device innovation has focused on improving dose conformity, reducing shielding requirements, and enabling mobility, which collectively lower barriers to adoption in ambulatory and community hospital environments. As a result, clinical teams can contemplate delivering radiotherapy at the point of tumor resection with greater precision and fewer logistical constraints than in earlier generations of equipment.

Concurrently, evidence synthesis and real-world outcomes reporting have improved clarity around patient selection, enabling more nuanced decisions about which cohorts may derive the most meaningful benefit from a single-session intraoperative approach. These clinical refinements are complemented by evolving training frameworks that emphasize interdisciplinary coordination, safety culture, and reproducible procedural workflows. Because of these developments, institutions that once deferred adoption due to operational complexity are re-evaluating their strategies and piloting IORT programs with cross-functional support.

Financial and policy environments are also shifting, with greater attention to value-based care models and care consolidation. Stakeholders are assessing how IORT might reduce the overall treatment burden for patients by compressing therapy into the operative episode, potentially enhancing patient experience and adherence. Taken together, these forces represent a structural shift in how local control strategies can be integrated into the surgical episode, prompting both providers and manufacturers to adapt commercialization, training, and service models in response.

Assessing how recent tariff and trade dynamics can alter procurement decisions, supply chain resilience, and deployment strategies for intraoperative radiation therapy systems

Tariff policies affecting medical device imports can reverberate across supply chains, procurement strategies, and the economics of deploying advanced intraoperative radiation therapy systems. Increased duties or trade restrictions raise landed costs for imported equipment and components, which in turn can prompt purchasing organizations to re-evaluate acquisition timing, financing arrangements, and vendor selection. When procurement teams anticipate variable import costs, there is often a tendency to prefer suppliers with regional manufacturing footprints or diversified sourcing strategies to mitigate exposure.

Moreover, tariffs can influence the competitive dynamics among device manufacturers. Firms with established domestic production capabilities or localized assembly may be better positioned to maintain stable pricing and competitive lead times, while those reliant on cross-border component flows may absorb costs or pass them on to buyers. In addition to direct price effects, tariffs can affect service and maintenance economics if replacement parts and consumables become subject to additional duties, thereby influencing total cost of ownership considerations for health systems assessing IORT investments.

From a clinical operations perspective, procurement delays or higher equipment costs may slow program rollout timelines, prompting institutions to prioritize phased implementations, shared-service models, or partnerships that spread capital commitments. In turn, these adaptations can change where and how IORT services are offered, with potential implications for access in community settings versus academic centers. Ultimately, trade policy shifts underscore the importance of resilient supply chain planning, transparent cost modeling, and strategic vendor engagement to preserve implementation momentum for intraoperative radiation therapy initiatives.

Key segmentation insights revealing how clinical application, delivery technology, and care setting jointly determine adoption pathways and procedural design choices

Segmentation analysis reveals nuanced drivers of adoption and clinical value across application, technology, and end-user dimensions. Based on Application, the technology is applied across Brain Tumors, Breast Cancer, and Gynecological Cancer, each presenting distinct surgical workflows, dosimetric requirements, and multidisciplinary coordination needs that influence device selection and protocol design. Brain tumor procedures often demand high precision and specialized shielding considerations; breast cancer cases offer opportunities for single-fraction approaches tied to breast conservation strategies; gynecologic malignancies can leverage intraoperative boosts in complex pelvic resections where margin control is critical.

Based on Technology, offerings fall into categories including Electron, Low Energy X Ray, and Portable X Ray, with each modality presenting trade-offs in penetration depth, shielding infrastructure, and operating room integration. Electron-based systems deliver deeper tissue penetration suitable for certain tumor beds but often require more extensive shielding. Low energy X-ray platforms provide surface-weighted dose distributions favorable for select indications and may reduce shielding burdens. Portable X-ray devices prioritize mobility and streamlined workflows, enabling adoption in a wider range of surgical settings but with distinct clinical and dosimetric implications.

Based on End User, typical settings include Ambulatory Surgery Center, Cancer Center, and Hospital, each of which has different capital investment tolerance, staffing models, and patient throughput expectations that shape program feasibility. Ambulatory surgery centers may prioritize compact, low-footprint solutions that minimize capital and operational overhead, while cancer centers and hospitals can invest in more comprehensive infrastructure and multidisciplinary programs. Recognizing these segmentation dimensions helps stakeholders align technology choice, clinical protocols, and service delivery models to institutional capabilities and patient population needs.

Regional dynamics and adoption patterns that influence clinical program development, reimbursement alignment, and distribution strategies across global health markets

Regional perspectives on intraoperative radiation therapy highlight distinct drivers and barriers across major geographies. In the Americas, clinical networks and tertiary centers have been early adopters, supported by robust surgical oncology programs and a focus on consolidating perioperative care; however, variations in reimbursement practices and capital cycles influence where programs scale beyond major metropolitan centers. Transitional initiatives in community hospitals and selected ambulatory settings are increasingly visible as institutions seek to enhance local access to advanced oncologic therapies.

In Europe, Middle East & Africa, heterogeneous healthcare systems produce a mosaic of adoption patterns. High-resource centers in Western Europe have integrated IORT into specialized pathways, while some regions prioritize centralized delivery in referral institutions to concentrate expertise and manage resource utilization. Regulatory harmonization efforts and cross-border clinical collaborations play a role in knowledge dissemination and training, enabling centers of excellence to catalyze broader regional capability building.

In Asia-Pacific, rapid growth of surgical oncology services, investments in cancer infrastructure, and interest in portable and low-footprint devices are driving exploratory programs across both urban and peri-urban hospitals. Diverse payer models and evolving clinical guidelines shape adoption, and partnerships between local distributors and technology providers often determine the feasibility of expanding access. Across all regions, workforce training, radiation safety infrastructure, and alignment of clinical pathways remain central to sustainable program development.

Strategic competitive positioning and service-driven differentiators shaping supplier selection, clinical adoption, and long-term program sustainability in intraoperative radiation therapy

The competitive environment for intraoperative radiation therapy comprises established medical device firms, specialist radiation companies, and emerging entrants focused on novel delivery platforms and services. Players are differentiating through technological advancements such as compact generators, optimized applicators, and integrated imaging or navigation aids that enhance targeting and procedural efficiency. Strategic priorities include reducing shielding burdens, shortening setup times, and enabling seamless integration into the surgical workflow to lower operational friction and improve throughput.

Partnerships and service models are increasingly central to commercial strategies. Suppliers are offering bundled solutions that combine equipment with training programs, clinical support, and maintenance services to help healthcare providers achieve predictable implementation outcomes. Additionally, clinical evidence generation and post-market registries are becoming important competitive levers; firms that can demonstrate reproducible outcomes, procedural efficiency, and safety across diverse practice settings gain credibility with institutional purchasers and clinical champions.

Investment in after-sales support and regional service networks also affects adoption, particularly where uptime and rapid technical response are critical to surgical scheduling. As a result, companies that align product design with practical clinical workflows and offer robust education and service infrastructure are better positioned to influence program design decisions and long-term purchasing relationships.

Actionable recommendations for healthcare executives and clinical leaders to implement intraoperative radiation therapy programs with operational rigor and measurable outcomes

Leaders considering IORT adoption should prioritize actionable steps that align clinical value with operational feasibility. First, establish multidisciplinary governance that includes surgical, radiation oncology, medical physics, nursing, and administrative stakeholders to create reproducible protocols, define safety checklists, and manage training pathways. Early engagement across these groups accelerates consensus on patient selection criteria and procedural responsibilities, reducing implementation risk and ensuring consistent quality of care.

Second, evaluate procurement options that balance device capabilities with institutional workflow constraints. Consider total lifecycle implications including consumables, service contracts, and supply chain resilience. Where trade policy or sourcing risks exist, prioritize vendors with local assembly or diversified supply chains to preserve operational continuity. Pilot programs with phased scale-up can validate clinical and economic assumptions while providing necessary data to refine protocols.

Third, invest in outcome measurement and knowledge dissemination by establishing registries or participating in collaborative data initiatives. Transparent reporting on clinical outcomes, complication rates, and patient experience supports internal decision-making and external stakeholder confidence. Finally, align reimbursement and financial planning with clinical objectives by engaging payers early to articulate the potential patient-centric benefits and to explore case-based or bundled payment approaches that reflect the procedural consolidation enabled by intraoperative radiotherapy.

Transparent research methodology combining primary expert interviews, secondary clinical and regulatory analysis, and triangulated validation to ensure actionable and reliable insights

The research approach underpinning this analysis blended qualitative and quantitative techniques to produce a comprehensive view of intraoperative radiation therapy adoption, supply dynamics, and clinical practice patterns. Primary research included interviews with surgical oncologists, radiation oncologists, medical physicists, procurement leads, and device specialists to capture frontline operational insights and to identify barriers and enablers observed in real-world implementations. Secondary analysis comprised peer-reviewed clinical literature, regulatory documentation, health system reports, and publicly available technical specifications to corroborate clinical and technical assertions.

Triangulation methods were applied to reconcile differing perspectives and to ensure findings reflect both clinical evidence and operational realities. This included cross-referencing interview findings with device specifications and training frameworks, and validating regional adoption narratives against institutional case studies. In addition, scenario analysis was used to explore how supply chain disruptions, policy changes, or technological shifts could influence procurement and deployment choices, with an emphasis on practical implications rather than numerical forecasting.

Finally, quality controls included expert review of draft findings by clinicians and health system administrators to ensure accuracy, relevance, and applicability. The resulting synthesis emphasizes actionable insights, readiness considerations, and strategic options designed to support decision-making for clinical program leaders and commercial stakeholders.

Concluding synthesis on how technological progress and operational readiness together determine the sustainable integration of intraoperative radiation therapy within oncologic care pathways

Intraoperative radiation therapy stands at an inflection point where technological maturity, clinical evidence, and service model innovation converge to offer new pathways for perioperative oncologic care. Devices that reduce operational complexity and shielding requirements, coupled with standardized training and multidisciplinary governance, create realistic pathways for expanded adoption beyond early adopter institutions. This evolution promises improved integration of local control strategies into single-encounter surgical care while also demanding careful attention to implementation logistics and long-term service commitments.

As care delivery and procurement landscapes evolve, stakeholders should approach IORT adoption with a balanced view that weighs clinical potential against operational, regulatory, and supply chain realities. Effective programs will be those that plan comprehensively: defining clinical indications clearly, investing in multidisciplinary training, ensuring device selection aligns with institutional workflows, and establishing mechanisms for outcome measurement and continual improvement. When these elements are combined, IORT can become a reliable component of contemporary oncologic practice, improving the patient experience while fitting into broader strategic objectives for surgical and radiation oncology services.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intraoperative Radiation Therapy Market, by Technology

  • 8.1. Electron
  • 8.2. Low Energy X Ray
  • 8.3. Portable X Ray

9. Intraoperative Radiation Therapy Market, by Product Type

  • 9.1. IORT Equipment / Radiation Systems
    • 9.1.1. Mobile electron accelerators
    • 9.1.2. Miniaturized X-ray IORT systems
  • 9.2. Applicators & Accessories
    • 9.2.1. Spherical applicators
    • 9.2.2. Flat applicators

10. Intraoperative Radiation Therapy Market, by Procedure / Surgical Approach

  • 10.1. Breast-Conserving Surgery (BCS)
  • 10.2. Tumor Bed Boost During Cancer Surgery
  • 10.3. Debulking Surgery + Radiation Boost

11. Intraoperative Radiation Therapy Market, by Procedure Setting

  • 11.1. Inpatient Surgical Procedures
  • 11.2. Outpatient / Day-Care Procedures

12. Intraoperative Radiation Therapy Market, by Cancer Application

  • 12.1. Brain Tumors
  • 12.2. Breast Cancer
  • 12.3. Gynecological Cancer

13. Intraoperative Radiation Therapy Market, by End User

  • 13.1. Ambulatory Surgery Center
  • 13.2. Cancer Center
  • 13.3. Hospital

14. Intraoperative Radiation Therapy Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Intraoperative Radiation Therapy Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Intraoperative Radiation Therapy Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Intraoperative Radiation Therapy Market

18. China Intraoperative Radiation Therapy Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Accuray Incorporated
  • 19.6. Aries Medical Systems Ltd.
  • 19.7. Brainlab AG
  • 19.8. Carl Zeiss Meditec AG
  • 19.9. Eckert & Ziegler Radiopharma
  • 19.10. Elekta AB
  • 19.11. GMV Innovating Solutions
  • 19.12. iCAD, Inc.
  • 19.13. InfoMedics AG
  • 19.14. IntraOp Medical, Inc.
  • 19.15. Ion Beam Applications SA
  • 19.16. Isoray, Inc.
  • 19.17. Panacea Medical Technologies Pvt. Ltd.
  • 19.18. Salutaris Medical Devices
  • 19.19. Sensus Healthcare, Inc.
  • 19.20. Sordina IORT Technologies
  • 19.21. Varian Medical Systems, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PROCEDURE / SURGICAL APPROACH, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PROCEDURE SETTING, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY CANCER APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY ELECTRON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY ELECTRON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY ELECTRON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY LOW ENERGY X RAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY LOW ENERGY X RAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY LOW ENERGY X RAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PORTABLE X RAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PORTABLE X RAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PORTABLE X RAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY IORT EQUIPMENT / RADIATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY IORT EQUIPMENT / RADIATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY IORT EQUIPMENT / RADIATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY IORT EQUIPMENT / RADIATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY MOBILE ELECTRON ACCELERATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY MOBILE ELECTRON ACCELERATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY MOBILE ELECTRON ACCELERATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY MINIATURIZED X-RAY IORT SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY MINIATURIZED X-RAY IORT SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY MINIATURIZED X-RAY IORT SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATORS & ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATORS & ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATORS & ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATORS & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY SPHERICAL APPLICATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY SPHERICAL APPLICATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY SPHERICAL APPLICATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY FLAT APPLICATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY FLAT APPLICATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY FLAT APPLICATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PROCEDURE / SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY BREAST-CONSERVING SURGERY (BCS), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY BREAST-CONSERVING SURGERY (BCS), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY BREAST-CONSERVING SURGERY (BCS), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TUMOR BED BOOST DURING CANCER SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TUMOR BED BOOST DURING CANCER SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TUMOR BED BOOST DURING CANCER SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY DEBULKING SURGERY + RADIATION BOOST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY DEBULKING SURGERY + RADIATION BOOST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY DEBULKING SURGERY + RADIATION BOOST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PROCEDURE SETTING, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY INPATIENT SURGICAL PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY INPATIENT SURGICAL PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY INPATIENT SURGICAL PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY OUTPATIENT / DAY-CARE PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY OUTPATIENT / DAY-CARE PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY OUTPATIENT / DAY-CARE PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY CANCER APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY BRAIN TUMORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY BRAIN TUMORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY BRAIN TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY BREAST CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY GYNECOLOGICAL CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY GYNECOLOGICAL CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY GYNECOLOGICAL CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY CANCER CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY CANCER CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY CANCER CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY IORT EQUIPMENT / RADIATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATORS & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PROCEDURE / SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PROCEDURE SETTING, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY CANCER APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY IORT EQUIPMENT / RADIATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATORS & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PROCEDURE / SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PROCEDURE SETTING, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY CANCER APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY IORT EQUIPMENT / RADIATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATORS & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PROCEDURE / SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PROCEDURE SETTING, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY CANCER APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY IORT EQUIPMENT / RADIATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATORS & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PROCEDURE / SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PROCEDURE SETTING, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY CANCER APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY IORT EQUIPMENT / RADIATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATORS & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PROCEDURE / SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PROCEDURE SETTING, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY CANCER APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY IORT EQUIPMENT / RADIATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATORS & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PROCEDURE / SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PROCEDURE SETTING, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY CANCER APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY IORT EQUIPMENT / RADIATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATORS & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PROCEDURE / SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PROCEDURE SETTING, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY CANCER APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY IORT EQUIPMENT / RADIATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATORS & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PROCEDURE / SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PROCEDURE SETTING, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY CANCER APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY IORT EQUIPMENT / RADIATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATORS & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PROCEDURE / SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PROCEDURE SETTING, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY CANCER APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. GCC INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. GCC INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. GCC INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. GCC INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY IORT EQUIPMENT / RADIATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 157. GCC INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATORS & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 158. GCC INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PROCEDURE / SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 159. GCC INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PROCEDURE SETTING, 2018-2032 (USD MILLION)
  • TABLE 160. GCC INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY CANCER APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. GCC INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY IORT EQUIPMENT / RADIATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATORS & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PROCEDURE / SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPEAN UNION INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PROCEDURE SETTING, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY CANCER APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY IORT EQUIPMENT / RADIATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATORS & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PROCEDURE / SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PROCEDURE SETTING, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY CANCER APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. BRICS INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. G7 INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. G7 INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 182. G7 INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. G7 INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY IORT EQUIPMENT / RADIATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 184. G7 INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATORS & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 185. G7 INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PROCEDURE / SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 186. G7 INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PROCEDURE SETTING, 2018-2032 (USD MILLION)
  • TABLE 187. G7 INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY CANCER APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. G7 INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. NATO INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. NATO INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. NATO INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. NATO INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY IORT EQUIPMENT / RADIATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 193. NATO INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATORS & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 194. NATO INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PROCEDURE / SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 195. NATO INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PROCEDURE SETTING, 2018-2032 (USD MILLION)
  • TABLE 196. NATO INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY CANCER APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. NATO INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED STATES INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY IORT EQUIPMENT / RADIATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATORS & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 204. UNITED STATES INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PROCEDURE / SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED STATES INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PROCEDURE SETTING, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED STATES INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY CANCER APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 207. UNITED STATES INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 209. CHINA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 210. CHINA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. CHINA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY IORT EQUIPMENT / RADIATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 212. CHINA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATORS & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 213. CHINA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PROCEDURE / SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 214. CHINA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PROCEDURE SETTING, 2018-2032 (USD MILLION)
  • TABLE 215. CHINA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY CANCER APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. CHINA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)